REX

REX is a rare commodity processor with a fortress balance sheet: $189M cash (and ~$375.8M cash plus short-term investments per the MD&A), a 5.9x current ratio, $372.5M of working capital, and effectively no parent-level debt — the provided 'total liabilities $121K' and 'L/E 0.00x' lines are clearly mislabeled artifacts (FY2018/FY2014 tags), but the MD&A confirms no restricted net assets at the parent or subsidiaries. On those bones, FY2026 was a record year: net income $95.1M (+33%), diluted EPS $2.50 (+51.5%), ROE 15.6%, and operating cash flow up 83.6% to $118M. Management is returning capital opportunistically, buying 1.65M shares for $32.9M 'when management deems the shares are trading at a discount to intrinsic value.' That is a genuinely high-quality setup.

The problem is what you're paying for and when. Ethanol is a pure crush-spread business — the 10-K is explicit that returns are 'highly dependent on commodity prices' for corn, natural gas, ethanol and distillers grains, and that a 'sustained narrow or negative spread' produces operating losses. Revenue tells the cyclical story plainly: $855M (FY2023) → $833M → $642M → $650M, so the top line is well off peak even as margins (14.6% net) and EPS hit records, partly aided by 45Z clean-fuel credits (the MD&A references prevailing-wage/EAC accruals tied to 45Z recognition). Paying a 17.9x reported P/E and 2.3x sales for a commodity producer at peak earnings is the classic value-trap geometry — the multiple looks cheaper on an ex-cash/EV basis (~$1.1B EV on $95M earnings), which is what keeps this a hold rather than a sell.